By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301




Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.

Company News
Argos Therapeutics, Inc. (ARGS) Announces Update On Phase 3 ADAPT Trial To Be Presented During 2015 ASCO Genitourinary Cancers Symposium 2/27/2015 7:14:23 AM
Joan C. Winterbottom Joins Argos Therapeutics, Inc. (ARGS) As Chief Human Resources Officer 2/24/2015 7:30:43 AM
Argos Therapeutics, Inc. (ARGS) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2015 7:53:38 AM
Argos Therapeutics, Inc. (ARGS) Chief Operating Officer To Speak At Phacilitate Cell & Gene Therapy Forum 2015 1/23/2015 10:11:22 AM
Argos Therapeutics, Inc. (ARGS) Director Of Immunology To Speak At The GTCbio Novel Immunotherapeutics Summit 2015 1/22/2015 8:35:38 AM
Argos Therapeutics, Inc. (ARGS) Chief Scientific Officer To Speak At The Personalized Medicine World Conference 2015 1/20/2015 7:53:51 AM
Argos Therapeutics, Inc. (ARGS) Provides Update On Clinical Research For Investigational Fully Personalized Immunotherapy For The Treatment Of HIV 1/9/2015 7:52:29 AM
Argos Therapeutics, Inc. (ARGS) To Present At Biotech Showcase 2015 1/7/2015 7:51:13 AM
Argos Therapeutics, Inc. (ARGS) And Saint-Gobain Performance Plastics Announce Agreement For Production Of Disposables Used In Automated Manufacturing Of Fully Personalized Immunotherapies 1/6/2015 7:28:32 AM
Argos Therapeutics, Inc. (ARGS) Receives 2014 Red Herring North America Top 100 Award 12/1/2014 4:16:37 PM